DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, announced today the Dexcom G7 15 Day Continuous Glucose ...

Dexcom announced the Dexcom G7 15 Day Continuous Glucose Monitoring System for people over the age of 18 with diabetes will ...

The global Blood Glucose Monitoring System Market, valued at US$15.16 billion in 2024, stood at US$16.46 billion in 2025 and ...

Dexcom’s “Smart Basal” has received FDA clearance for people with type 2 diabetes using long-acting insulin. The feature will ...

A medical technology firm specialising in continuous glucose monitoring systems for diabetes is set to relocate to Maxis Business Park in Bracknell.

Dr. Casey Means & Dr. Andrew Huberman talk about the usage of CGM. Petition Forcing Epstein Vote Succeeds Over White House ...

India lives with diabetes at a scale few nations do. More than 100 million adults are managing the condition, and many more ...

Lifecare AS ( ($DE:LFC0) ) has shared an announcement. Lifecare ASA has published its Q3 2025 financial report, highlighting significant progress ...

Diabetes is a chronic condition that affects millions of people worldwide, and managing blood glucose levels is one of the most critical aspects of diabetes care. For ...

Frequent use vs nonuse of a continuous glucose monitoring device is associated with improved long-term glycemic control in ...

Dexcom has obtained an FDA clearance for its basal insulin dosing optimizing program, designed for adults with Type 2 diabetes using its continuous glucose monitors.  | Dexcom said Smart Basal is the ...

Continuous Glucose Monitoring Systems (CGMS) have emerged as pivotal tools in the management of diabetes, offering real-time insights into glucose levels and revolutionizing patient care. The market ...